CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · IEX Real-Time Price · USD
4.863
-0.087 (-1.76%)
At close: Jul 19, 2024, 4:00 PM
4.950
+0.087 (1.79%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 75 employees as of December 31, 2023. The number of employees increased by 2 or 2.74% compared to the previous year.
Employees
75
Change (1Y)
2
Growth (1Y)
2.74%
Revenue / Employee
$141,653
Profits / Employee
-$99,987
Market Cap
55.70M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Allurion Technologies | 504 |
Neuronetics | 203 |
Cytosorbents | 186 |
LENSAR | 130 |
Adlai Nortye | 127 |
Passage Bio | 58 |
Rallybio | 43 |
Immix Biopharma | 17 |
CLGN News
- 6 weeks ago - CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data - PRNewsWire
- 7 weeks ago - CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update - PRNewsWire
- 2 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 4 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 5 months ago - CollPlant Issues Letter to Shareholders - PRNewsWire
- 7 months ago - CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California - PRNewsWire
- 7 months ago - CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants - PRNewsWire